Simian virus 40 (SV40) mutant 5002 carries base pair substitutions of C-5109-*T and C-5082-*T. These mutations lie in a region of the genome that encodes amino acids common to the large and small viral tumor antigens (T and t antigens, respectively) and result in amino acid substitutions of Leu-19-*Phe and Pro-28--*Ser. In contrast to wild-type SV40, which produces large plaques that are clearly visible 8 days postinfection, mutant 5002 is defective for productive infection, producing tiny plaques that arise at around 21 days postinfection. However, 5002 is capable of replicating viral DNA and producing normal amounts of capsid proteins, indicating that the mutations alter an activity of T antigen that is required subsequent to DNA synthesis, such as maturation, viral assembly, or release of virions. The mutant T antigen has normal ATPase activity, is phosphorylated in a manner that is indistinguishable from that of the wild-type T antigen, and retains the ability to oligomerize. 5002 complements mutants defective in T antigen host range-adenovirus helper function for productive infection. Thus, T antigen encodes two activities that affect at least two different steps in viral infection other than DNA replication, one inactivated by mutations in the host range-adenovirus helper domain and one inactivated by the mutations present in 5002. The 5002-encoded T antigen is also defective for transformation of REF52 cells when expressed from the normal SV40 early promoter, although this defect can be partially overcome by expressing the protein from stronger promoters.
The large tumor antigen (T antigen) of simian virus 40 (SV40) is a multifunctional regulatory protein that is required for a number of steps in productive viral infection, including DNA replication and regulation of transcription (see references 5, 13, 38, and 49 for reviews). In addition, T antigen is necessary and, in most cases, sufficient for virus-induced tumorigenesis in animals and morphological transformation of cells in culture. One approach to understanding how T antigen carries out these multiple functions is to study mutants that carry specific changes in various regions or domains of the molecule. The study of such mutants has indicated that some of the activities of T antigen are localized to discrete functional domains and has allowed correlation of known biochemical activities with specific biological effects.
Studies of the effects of different mutations on viral DNA replication, production of infectious virions, and the ability to induce morphological transformation have revealed five distinct phenotypes: (i) mutants that coordinately lose all three functions (23, 27, 36, 47) ; (ii) mutants defective for viral DNA replication and productive infection but positive for transformation (12, 22, 31, 45) ; (iii) mutants that show a trans-dominant defect for replication but are capable of transformation (14) ; (iv) mutants positive for viral DNA replication and transformation but incapable of producing infectious progeny virions (34, 50) ; and (v) mutants positive for viral DNA replication but defective for transformation and infectious virion production (10, 22, 39) . Of this last class of mutants, the best studied is tsA1642, which carries a single amino acid substitution of Pro-453-*Ser. This mutant replicates viral DNA at all temperatures but is heat sensitive for productive infection and cold sensitive for transformation (10) . tsA1642 synthesizes late viral proteins at the nonpermissive temperature, indicating that the block to infection lies in viral assembly or release and implying that T antigen plays a direct or indirect role in these processes. The basis for the conditional transformation defect is not known.
Here we report the preliminary characterization of another mutant, 5002, that is positive for viral DNA replication but defective for infectious virion production and transformation. The defects in 5002 are nonconditional, i.e., the virus fails to form normal plaques at any of the temperatures tested. Furthermore, the mutations present in 5002 map toward the amino terminus of T antigen and in a domain different from that of the tsA1642 lesion. Our studies support the contention that a T-antigen-encoded function plays a role in a late stage of viral infection and that this function is separate from that defined by mutations that affect the host range (HR)-adenovirus helper domain. This same activity may play a role in the morphological transformation of cells in culture.
been described previously (31, 33) . Plasmid pcDneo, which carries G418 resistance, has also been described before (6) .
Mutagenesis and DNA sequencing. Mutant 5002 was generated by site-directed mutagenesis by the heteroduplex mutagenesis procedure of Peden and Nathans (30) . d11135 (32, 36) , a deletion mutant missing SV40 base pairs 5114 to 5082, was used to direct the position of the heteroduplex loop, and sodium bisulfite was the mutagen. The base pair substitutions present in 5002 were determined by DNA sequence analysis as described by Maxam and Gilbert (28) , and the reaction products were fractionated by electrophoresis in 8% polyacrylamide gels in 8 M urea (40) .
Plaque assays. Growth and titration of wild-type and mutant SV40 on BSC40 and CV1 cells were essentially as described before (3, 4) , except that mutant 5002 required incubation for a much longer period (see Results). For photography, the agar was carefully removed and the cell monolayers were stained with 1% crystal violet in 20% ethanol. Plaque and complementation assays of mutant DNAs after DEAE-dextran transfection were done as previously described (34, 36) . The mutation was marker rescued by using the SV40 HaeIII E fragment (nucleotides 5234 to 4862) and the HindlIl B fragment (nucleotides 5171 to 4001) as described before (31) . Viral (18) were applied directly to the medium, and the cells were incubated for 4 h. The cells were then washed twice with medium and glycerol shocked (17) , and fresh medium was added; incubation was at 37°C. After 48 h, the cells were trypsinized and split 1:3. Foci were scored after 4 to 6 weeks. For selection of G418-resistant colonies, the medium contained 400 ,ug of G418 per ml and colonies were picked 3 to 4 weeks later.
Immunoprecipitation and Western blot (immunoblot) analysis of viral proteins. Viral T antigens were examined by immunoprecipitation with hamster anti-T-antigen polyclonal serum (26) . Subconfluent cells were labeled for 3 to 4 h in methionine-free medium containing 100 20 ,000 x g for 45 min to remove cell debris (46) . About 600 pul of extract was recovered per 15-cmdiameter dish. Labeled extracts were immunoprecipitated with the T-antigen-specific PAb419 antibody (21) by using saturating amounts of antibody and protein A-Sepharose (Pharmacia, Inc., Piscataway, N.J.) as previously described (46) . Immune Phosphopeptide mapping and phosphoamino acid analysis. Each (10-cm-diameter) dish of cells was labeled with 10 mCi of 32Pi in 5 to 10 ml of phosphate-free Dulbecco modified Eagle medium plus 5% dialyzed calf serum, and extracts were prepared at 40 h p.i. as described above. 32P-labeled T antigen bands from 1 x 107 to 2 x 107 SV40-infected cells were extracted from dried polyacrylamide-SDS gels, oxidized, and digested with trypsin as previously described (1). Phosphopeptides were separated on 100-,um-thick cellulose thin-layer plates by electrophoresis (pH 1.9; 1 kV for 40 min) in the first dimension and chromatography (isobutyric acidpyridine-acetic acid-butanol-H20 [66:5:3:2:29, vol/vol]) in the second dimension (41) . Phosphoamino acid analyses were done by partially hydrolyzing peptides in 5.7 M HCl at 110°C for 1 h and separating the phosphoamino acids on 100-p.m-thick cellulose thin-layer plates by electrophoresis at pH 1.0 (1.5 kV for 20 min) in the first dimension and pH 3.5 (1.3 kV for 16 min) in the second (9) . Labeled peptides and amino acids were visualized by autoradiography with sensitized Kodak X-Omat AR film.
RESULTS
Preliminary characterization of T-antigen mutant 5002. Mutant 5002 was one of a number of mutants containing lesions directed to the amino-terminal exon of the SV40 large T-antigen gene (Peden and Pipas, unpublished data). This region is shared by the small t and large T antigens and is highly conserved among all of the members of the polyomavirus group. Site-directed mutagenesis was carried out as previously described (30, 31) . DNA sequence analysis of mutant 5002 revealed two base pair changes of C-5109-*T and C-5082->T, which resulted in amino acid substitutions of Leu-19-->Phe and Pro-28--*Ser, respectively (Fig. 1) . A leucine occurs at position 19 in five of the six T-antigen sequences reported to date (SV40 [15, 37] , BK virus [42, 53] , JC virus [16] , hamster papovavirus [12] , and polyomavirus [43] ), the only exception being lymphotropic papovavirus (29) , in which the corresponding residue is an isoleucine.
To test the effects of these mutations on virus viability, plaque assays were performed on two permissive cell lines, Fig. 2 ). This defect could be corrected by complementation with a wildtype T antigen provided in trans by d11007, a mutant defective for normal capsid protein synthesis (24, 25) . When the plaque assays at 37°C were extended to 21 days, small pinpoint plaques became visible (Fig. 2) Accumulation of late capsid proteins VP1, VP2, and VP3 was examined by Western analysis after infection of BSC40 cells. These experiments showed that VP1, VP2, and VP3 accumulated to about the same levels in wild-type-and 5002-infected cells (Fig. 5) . Since viral nucleic acid replication and late protein synthesis were not seriously impaired, the block to infection caused by the 5002 mutation must involve virus assembly, maturation, or release of virions from the cell. (20) . Foci of morphologically transformed cells were scored at 4 to 6 weeks. 5002 was defective for transformation on the REF52 cell line but was able to induce foci on the C3H1OT1/2 cell line at a level of about 10% of that of the wild type (Table 3 ). This cell type specificity for transformation has been reported previously for T-antigen deletion and amino acid substitution mutants (33, 35, 44; Srinivasan et al., unpublished data).
However, the transformation defect of 5002 in REF52 cells is not absolute, since this T antigen was capable of inducing foci at an efficiency that was 16% of that of the wild type when expressed from the mouse metallothionein I promoter and 5% of that of the wild type when expressed from the Rous sarcoma virus promoter (Table 4 ). The foci, however, were smaller than those induced by wild-type T antigen. In addition, the mouse metallothionein I promoter was three-to fourfold stronger than the simian virus 40 promoter in this assay (Table 4) . Furthermore, when 5002 was introduced into REF52 cells along with a plasmid (pcDneo) that confers resistance to G418, colonies of transformed cells arose with a level approximately equal to that elicited by wild-type T antigen (Table 5) . Thus, the 5002 transformation defect was apparent only in the focus assay.
The T antigens expressed in wild-type-and 5002-transformed cells were examined by immunoprecipitating 35S-labeled T antigens with hamster polyclonal anti-T-antigen serum (Fig. 6) half-life of 6 to 8 h in both cell types (Fig. 7) . Wild-type T antigen had approximately the same half-life in these cells (data not shown). Thus, the cell type-specific transformation demonstrated by 5002 is not due to differential stability of the mutant T antigen in the different cell lines. Oligomerization and ATPase activity. PAb419 immunecomplexed 5002 and wild-type T antigens from transformed C3H1OT1/2cells were analyzed for ATPase activity as described in Materials and Methods. Labeled T antigens were quantified, and the specific activity for ATP hydrolysis was calculated. 5002 T antigen consistently had a slightly elevated relative ATPase specific activity than the wild type (1.35 versus 1.0, respectively).
Wild-type T antigen forms oligomers and consists predominantly of 14S and 20S complexes (5, 13, 49) . To Immunoprecipitates were recovered with Pansorbin, washed, and analyzed on a 10% polyacrylamide-SDS gel. Cell lines containing 5080 T antigen, a mutant protein that does not bind p53 (33) , were included as negative controls. Lanes: 1, 5080; 2, 5002; 3, wild type; lanes 1), 4 h (lanes 2), 8 h (lanes 3), 16 h (lanes 4) , and 24 h (lanes 5) of chasing, and total protein concentrations were estimated. Lysates equivalent to 100 ,ug of total protein were immunoprecipitated with hamster anti-T serum and analyzed by polyacrylamide gel electrophoresis and autoradiography.
antigen was similar to that of 5002 T antigen, except that the ratio of 14S/20S forms was reduced (Fig. 8) .
Phosphorylation of 5002 T antigen. SV40 mutant 5002 and wild-type T antigens from transformed C3H1OT1/2 cells were metabolically labeled for 4 h with 32Pi and in parallel with [35S]methionine. Hypotonic extracts were immunoprecipitated with PAb1O9 to isolate total T antigen and Tantigen-p53 complexes and analyzed by polyacrylamide-SDS gel electrophoresis (Fig. 9) . Both the T-antigen and p53 bands were labeled. Quantification of 35S-labeled proteins barely detectable amounts of 32P-labeled free p53. Subsequent treatment of the supernatant with PAb122 (anti-p53) indicated that essentially all of the T-antigen-p53 complex had been precipitated in the first round and that there was little free p53 ( Fig. 9A and B, lanes 4 and 6) . Parallel immunoprecipitation of 32P-labeled extracts with anti-Tantigen and anti-p53 antibodies resulted in similar amounts of labeled T antigen and p53 bands for both cell lines (data not shown). This is consistent with binding of greater than 90% of the p53 to T antigen.
We observed that with increasing labeling time, a 35S-labeled 90-kDa band (p90) appeared in all immune-complexed T-antigen fractions from both wild-type-and 5002-transformed cell lines, regardless of whether anti-T-antigen or anti-p53 antibodies were used (Fig. 9) . There was little, if any, detectable p90 in untransformed C3H1OT1/2 cells. This p90 protein may be an altered form of T antigen or a cellular protein bound to T-antigen-p53 complexes. Whether or not p90 is phosphorylated is not clear.
To compare the phosphorylation sites of 5002 and wildtype T antigens, 32P-labeled proteins were extracted from polyacrylamide-SDS gels, oxidized, and digested with trypsin and the phosphopeptides were separated in two dimensions. Six phosphorylated tryptic peptides have been previously identified (41 The properties of 5002 resemble those of tsA1642, a temperature-sensitive mutant that replicates viral DNA even at the nonpermissive temperature but produces few infectious progeny virions. In addition, tsA1642 is conditionally defective for transformation (10) . Although tsA1642 has conditional defects and 5002 does not, since both mutants have defects in the production of infectious virions and in the ability to transform, we suggest that the same T-antigen function is altered in both cases. Since the 5002 changes are near the amino terminus of the protein while that in tsA1642 is in the ATPase-p53-binding domain, this function is affected by mutations in two different regions of the molecule. It is possible that this activity does not reside in a domain but rather requires some higher-order structure. Although the 5002-encoded T antigen retains the ability to form oligomeric complexes and to possess a normal pattern of phosphorylation, subtle changes in either of these might be difficult to detect.
Mutant 5002 is at least partially defective for the transformation of REF52 cells while retaining the ability to transform C3H1OT1/2 cells, although at a reduced efficiency relative to the wild type. This cell type specificity for transformation has been reported before (33, 35, 44) . In these studies, we proposed that T antigen encodes multiple activities involved in transformation. At least one of these resides within the amino-terminal domain of T antigen and is sufficient for transformation of C3H1OT1/2 cells, while another is affected by mutations within the ATPase-p53-binding domain but has not been localized to any particular region of the molecule. 5002 falls into the class of mutants capable of transforming C3H1OT1/2 cells but defective for transformation of the REF52 line. One possible explanation for this observation is that the second activity required for transformation of REF52 cells is not localized to a domain but rather requires higher-order structure of the protein. Thus, mutations in distant regions of T antigen could inactivate this activity. An alternative explanation is that two activities are required to transform REF52 cells, i.e., the amino-terminal activity plus another one, but that the 5002 mutation only partially inactivates the amino-terminal activity; this partial activity is sufficient to allow induction of foci on the C3H10T1/2 line but not on the REF52 line. This latter explanation is consistent with the finding that 5002 can induce foci on REF52 cells if the T antigen is expressed from stronger promoters or if a G418 colony selection assay is used. A third possibility is that the 5002 mutation inactivates an activity of small t antigen that contributes to the transformation of REF52 cells. This is unlikely, since large T antigen is sufficient to transform this cell type in the absence of small t antigen. Recently, the product of the retinoblastoma susceptibility gene has been shown to complex with the adenovirus Ela proteins (52) and with the SV40 large T antigen (11) . Mutations near the amino terminus of T antigen abolish its ability to form this complex (11) . Thus, the ability of T antigen to complex with this protein is a candidate for the amino-terminal transforming activity we have described. Studies to assess the ability of the 5002-encoded T 
